
Inflammatory Disease Markers Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update
Description
Inflammatory Disease Markers Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update
Summary
GlobalData's Medical Devices sector report, “Inflammatory Disease Markers Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update provides comprehensive information about the Inflammatory Disease Markers pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Inflammatory Disease Markers are antigen/antibodies that detect specific antigen/antibodies produced by bone, cartilage or any other inflammatory disease activity.
Note:Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Inflammatory Disease Markers under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Inflammatory Disease Markers and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
- Identify and understand important and diverse types of Inflammatory Disease Markers under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date
Table of Contents
189 Pages
- Inflammatory Disease Markers Overview
- Inflammatory Disease Markers - Pipeline Products by Stage of Development
- Inflammatory Disease Markers - Pipeline Products by Segment
- Inflammatory Disease Markers - Pipeline Products by Territory
- Inflammatory Disease Markers - Pipeline Products by Regulatory Path
- Inflammatory Disease Markers - Pipeline Products by Estimated Approval Date
- Inflammatory Disease Markers - Ongoing Clinical Trials
- Inflammatory Disease Markers Companies - Pipeline Products by Stage of Development
- Inflammatory Disease Markers - Pipeline Products by Stage of Development
- Company Overview
- 4F Biotech Srl Company Overview
- Abcodia Ltd Company Overview
- Adaltis Srl Company Overview
- Age Labs AS Company Overview
- Albert Ludwigs University of Freiburg Company Overview
- AnaMar AB Company Overview
- Anteotech Ltd Company Overview
- Aqtual Inc Company Overview
- Arizona State University Company Overview
- AXO Science SAS Company Overview
- Beckman Coulter Inc Company Overview
- BIOHOPE Scientific SL Company Overview
- Biomedal SL Company Overview
- BioMEMS Diagnostics Inc Company Overview
- BiomX Inc Company Overview
- BioSIMS Company Overview
- Boditech Med Inc Company Overview
- BRI Pharma Co Ltd Company Overview
- Castle Biosciences Inc Company Overview
- CD Diagnostics Inc Company Overview
- CDI Laboratories Inc Company Overview
- Cernostics Inc Company Overview
- Chronix Biomedical Inc Company Overview
- Cincinnati Children's Hospital Medical Center Company Overview
- Crescendo Bioscience Inc Company Overview
- Cyted Ltd Company Overview
- Detact Diagnostics BV Company Overview
- Diafir Company Overview
- DiaSorin SpA Company Overview
- DSX Therapeutics LLC Company Overview
- EKF Diagnostics Holdings Plc Company Overview
- ELITechGroup Inc Company Overview
- EMD Millipore Corp Company Overview
- ET Healthcare Inc Company Overview
- Exagen Diagnostics Inc Company Overview
- Firalis SAS Company Overview
- French National Institute of Health and Medical Research Company Overview
- G Medical Health and Wellness Company Overview
- Genalyte Inc Company Overview
- Geneoscopy LLC Company Overview
- Genetic Analysis AS Company Overview
- Genfit SA Company Overview
- Ghent University Company Overview
- GoodGut SL Company Overview
- Guangzhou Wondfo Biotech Co Ltd Company Overview
- Helmholtz Center Munich German Research Center for Health and Environment GmbH Company Overview
- Ignyta Inc Company Overview
- InterVenn BioSciences Company Overview
- IPDx Immunoprofiling Diagnostics GmbH Company Overview
- IV Diagnostics Inc Company Overview
- Johns Hopkins University Company Overview
- KineMed Inc Company Overview
- Korea Basic Science Institute Company Overview
- Ladon Therapeutics Kft Company Overview
- Leiden University Company Overview
- LifeAssays AB Company Overview
- LightDeck Diagnostics Inc Company Overview
- Mabdx Inc Company Overview
- Medica Corp Company Overview
- Metabolon Inc Company Overview
- Morehouse School of Medicine Company Overview
- MyHealthChecked plc Company Overview
- MYND Diagnostics Ltd Company Overview
- Myriad Genetics Inc Company Overview
- Nagoya City University Company Overview
- Neoteryx LLC Company Overview
- Northwestern University Company Overview
- Ortho Clinical Diagnostics Holdings Plc Company Overview
- Oxford Biodynamics Plc Company Overview
- Paragraf Ltd Company Overview
- Phagolum Ltd. Company Overview
- Proplex Technologies Llc Company Overview
- Protagen AG Company Overview
- ProteinLogic Ltd Company Overview
- QSTAG Co Ltd Company Overview
- Queen Mary University of London Company Overview
- Roche Diagnostics Corp Company Overview
- ROMEG Therapeutics LLC Company Overview
- Scailyte AG Company Overview
- Siemens Healthcare Diagnostics Inc Company Overview
- Singulex Inc Company Overview
- SomaLogic Inc Company Overview
- SpinChip Diagnostics AS Company Overview
- SQI Diagnostics Inc Company Overview
- StageZero Life Sciences Ltd Company Overview
- Svar Life Science AB Company Overview
- The University of Manchester Company Overview
- The Walter and Eliza Hall Institute of Medical Research Company Overview
- Thermo Fisher Scientific Inc Company Overview
- Toscana Biomarkers Srl Company Overview
- University Health Network Company Overview
- University Hospital Hradec Kralove Company Overview
- University of Aberdeen Company Overview
- University of Auckland Company Overview
- University of California Company Overview
- University of California Los Angeles Company Overview
- University of California San Diego Company Overview
- University of California San Francisco Company Overview
- University of Gottingen Company Overview
- University of Newcastle Company Overview
- University of Oxford Company Overview
- University of Rochester Company Overview
- University of Warwick Company Overview
- University Rovira i Virgili Company Overview
- Aug 01, 2024: Geneoscopy's Novel Stool-Based RNA Platform Shows High Accuracy in Monitoring Crohn's Disease
- Jul 30, 2024: Scipher Medicine Launches a New Approach to Discover Treatment-Response-Predicting Biomarkers for Complex Diseases
- Jul 02, 2024: Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, July 24, 2024
- Jun 24, 2024: Recent Aga Clinical Practice Guideline Acknowledges That Individuals Who May Be at Increased Risk of Progression to Esophageal Cancer Might Be Identified Using Tissue-Based Biomarkers, Particularly Castle Biosciences' Tissuecypher Test
- Jun 17, 2024: GENFIT: New EASL-EASD-EASO Clinical Practice Guidelines for MASLD Include NIS2+ as Key Tool for Detecting At-Risk MASH
- Jun 17, 2024: Thermo Fisher Scientific Showcases Clinical Research Innovation at DIA Annual Meeting
- May 16, 2024: Oxford Biodynamics and King's College London Collaborate to Develop EpiSwitch Prognostic and Predictive Biomarkers for Best Prevention of Rheumatoid Arthritis Following the APIPPRA Trial
- May 16, 2024: Taking Cytokine Testing by Storm: Automated 7-Test Inflammation Panel from Siemens Healthineers Offers Faster Insights, More Information
- May 07, 2024: Siemens Healthineers on Track to Meet Fiscal Year 2024 Targets After Second Quarter
- Mar 18, 2024: Siemens Healthineers Intends to Close Fast Track Diagnostics
- Feb 21, 2024: Myriad Genetics to Release Fourth Quarter and Full Year 2023 Financial Results on February 27, 2024
- Jan 29, 2024: Siemens Healthcare Diagnostics Receives FDA 510(k) Clearance for Atellica CH High Sensitivity C-Reactive Protein 2 Assay
- Jan 03, 2024: Myriad Genetics to Present at 42nd Annual J.P. Morgan Healthcare Conference
- Jan 02, 2024: Bio-Rad's Management to Host Investor Meetings at J.P. Morgan's 42nd Annual Healthcare Conference
- Dec 20, 2023: Siemens Healthcare Diagnostics Receives 510(k) Clearance For CardioPhase hsCRP Assay
- Dec 06, 2023: GENFIT Announces Publication in the Journal of Hepatology on the Accurate Performance of NIS2+ as a Screening Tool for the Enrollment of Patients in MASH Clinical Trials
- Nov 28, 2023: Thermo Fisher Scientific Prices Offering Of $2.5 Bln Of Senior Notes
- Nov 16, 2023: Non-Invasive Paper Chip Developed To Diagnose Inflammation and Infection
- Sep 26, 2023: GENFIT Announces Publication in Nature Medicine Confirming the Performance of its NASH Diagnostic Technology
- Aug 28, 2023: Bio-Rad to Participate in Fireside Chat During Wells Fargo's 2023 Healthcare Conference
- Aug 17, 2023: Myriad Genetics to Host Investor Day on September 19, 2023
- Aug 16, 2023: LumiraDx to Announce Second Quarter Financial Results and Host Quarterly Conference Call on August 24
- Methodology
- About GlobalData
- Contact Us
- Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.